Drug information for XIGRIS
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
VIAL; INTRAVENOUS
20MG/VIAL
Prescription
DROTRECOGIN ALFA (ACTIVATED)
drotrecogin alfa activated
LILLY
125029
2011-12-20 Other Important Information from FDA
2007-03-31 Letter
2007-03-31 Label
2005-08-31 Letter
2005-07-07 Label
2005-01-26 Letter
2005-01-26 Label
2004-03-30 Letter
2004-03-30 Label
2004-03-30 Review
VIAL; INTRAVENOUS
5MG/VIAL
Prescription
DROTRECOGIN ALFA (ACTIVATED)
drotrecogin alfa activated
LILLY
"
Drug Adverse Effects information for XIGRIS
Role code
Indications
Reaction
# Reports
PS
SEPSIS
DEATH
1
PS
SEPSIS
DISSEMINATED INTRAVASCULAR COAGULATION
1
PS
SEPSIS
GENERAL PHYSICAL HEALTH DETERIORATION
1
PS
SEPSIS
INTERNATIONAL NORMALISED RATIO INCREASED
1
PS
SEPSIS
MULTI-ORGAN FAILURE
1
PS
SEPSIS
MYOCARDIAL INFARCTION
1
PS
SEPSIS
PLATELET COUNT DECREASED
1
PS
SEPSIS
RENAL FAILURE
1
PS
SEPSIS
RESPIRATORY FAILURE
1
PS
SEPSIS
SEPSIS
1
PS
SEPSIS
SEPTIC SHOCK
1
PS
SEPTIC SHOCK
BRAIN DEATH
2
PS
SEPTIC SHOCK
BRAIN OEDEMA
2
PS
SEPTIC SHOCK
CEREBRAL HAEMORRHAGE
1
PS
SEPTIC SHOCK
DEATH
1
PS
SEPTIC SHOCK
HAEMORRHAGE INTRACRANIAL
1
PS
SEPTIC SHOCK
SEPTIC SHOCK
1
C
ATRIAL FIBRILLATION
CIRCULATORY COLLAPSE
1
C
ATRIAL FIBRILLATION
VENTRICULAR TACHYCARDIA
1
C
SEPSIS
CIRCULATORY COLLAPSE
1
C
SEPSIS
VENTRICULAR TACHYCARDIA
1
Ads by Google